{"id":"https://openalex.org/W2014164137","doi":"https://doi.org/10.1007/s40261-014-0237-7","title":"Levetiracetam Pharmacokinetics in Japanese Subjects with Renal Impairment","display_name":"Levetiracetam Pharmacokinetics in Japanese Subjects with Renal Impairment","alternate_titles":[],"publication_year":2014,"publication_date":"2014-10-13","ids":{"openalex":"https://openalex.org/W2014164137","doi":"https://doi.org/10.1007/s40261-014-0237-7","mag":"2014164137","pmid":"https://pubmed.ncbi.nlm.nih.gov/25312351"},"language":"en","primary_location":{"id":"doi:10.1007/s40261-014-0237-7","doi":"https://doi.org/10.1007/s40261-014-0237-7","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s40261-014-0237-7","pdf_url":null,"source":{"id":"https://openalex.org/S138241747","display_name":"Clinical Drug Investigation","issn_l":"0114-2402","issn":["0114-2402","1173-2563","1179-1918","2196-4920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Drug Investigation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2014164137"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055545030","display_name":"Junichi Yamamoto","orcid":"https://orcid.org/0000-0003-3974-8596","observed_orcids":["https://orcid.org/0000-0003-3974-8596"]},"institutions":[{"id":"https://openalex.org/I4210128940","display_name":"UCB Pharma (Japan)","ror":"https://ror.org/030z9kz64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210128940","https://openalex.org/I85722119"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Junichi Yamamoto","raw_affiliation_strings":["UCB Pharma, Shinjuku Grand Tower, 8-17-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan, Junichi.Yamamoto@ucb.com","UCB Pharma, Shinjuku-ku, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Shinjuku Grand Tower, 8-17-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan, Junichi.Yamamoto@ucb.com","institution_ids":["https://openalex.org/I4210128940"]},{"raw_affiliation_string":"UCB Pharma, Shinjuku-ku, Japan","institution_ids":["https://openalex.org/I4210128940"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016899016","display_name":"Nathalie Toublanc","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I85722119","display_name":"UCB Pharma (Belgium)","ror":"https://ror.org/01n029866","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Nathalie Toublanc","raw_affiliation_strings":["UCB Pharma, Chemin du Foriest, 1420, Braine-l\u2019Alleud, Belgium","UCB Pharma Braine l'Alleud Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Chemin du Foriest, 1420, Braine-l\u2019Alleud, Belgium","institution_ids":["https://openalex.org/I85722119"]},{"raw_affiliation_string":"UCB Pharma Braine l'Alleud Belgium","institution_ids":["https://openalex.org/I85722119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111876053","display_name":"Yuji Kumagai","orcid":"https://orcid.org/0000-0001-6304-8878","observed_orcids":["https://orcid.org/0000-0001-6304-8878"]},"institutions":[{"id":"https://openalex.org/I64189623","display_name":"Kitasato University","ror":"https://ror.org/00f2txz25","country_code":"JP","type":"education","lineage":["https://openalex.org/I64189623"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuji Kumagai","raw_affiliation_strings":["Kitasato University, Kanagawa, Japan","Kitasato Univ., Kanagawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kitasato University, Kanagawa, Japan","institution_ids":["https://openalex.org/I64189623"]},{"raw_affiliation_string":"Kitasato Univ., Kanagawa, Japan","institution_ids":["https://openalex.org/I64189623"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042643544","display_name":"Armel Stockis","orcid":"https://orcid.org/0000-0002-0815-5264","observed_orcids":["https://orcid.org/0000-0002-0815-5264"]},"institutions":[{"id":"https://openalex.org/I85722119","display_name":"UCB Pharma (Belgium)","ror":"https://ror.org/01n029866","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Armel Stockis","raw_affiliation_strings":["UCB Pharma, Chemin du Foriest, 1420, Braine-l\u2019Alleud, Belgium","UCB Pharma Braine l'Alleud Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Chemin du Foriest, 1420, Braine-l\u2019Alleud, Belgium","institution_ids":["https://openalex.org/I85722119"]},{"raw_affiliation_string":"UCB Pharma Braine l'Alleud Belgium","institution_ids":["https://openalex.org/I85722119"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5016899016","https://openalex.org/A5055545030"],"corresponding_institution_ids":["https://openalex.org/I4210128940","https://openalex.org/I85722119"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":null,"fwci":1.6506,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.81853606,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"34","issue":"11","first_page":"819","last_page":"828"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.8618000149726868,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.8618000149726868,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.06679999828338623,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.027899999171495438,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/levetiracetam","display_name":"levetiracetam","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.996999979019165},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.9990000128746033},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hemodialysis","display_name":"hemodialysis","score":0.9340000152587891},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.7440000176429749},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.7369999885559082},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.7310000061988831},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.7200000286102295},{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.5709999799728394},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.8119999766349792}],"concepts":[{"id":"https://openalex.org/C2777332695","wikidata":"https://www.wikidata.org/wiki/Q417227","display_name":"Levetiracetam","level":3,"score":0.9310164451599121},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8393912315368652},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7136366367340088},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.6814440488815308},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6413787007331848},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.48544150590896606},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.4564320147037506},{"id":"https://openalex.org/C2778063415","wikidata":"https://www.wikidata.org/wiki/Q391744","display_name":"Hemodialysis","level":2,"score":0.4386172890663147},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4233681559562683},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3862130641937256},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3221699893474579},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.17624351382255554},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077287","descriptor_name":"Levetiracetam","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010889","descriptor_name":"Piracetam","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010889","descriptor_name":"Piracetam","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010889","descriptor_name":"Piracetam","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010889","descriptor_name":"Piracetam","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051437","descriptor_name":"Renal Insufficiency","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D051437","descriptor_name":"Renal Insufficiency","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s40261-014-0237-7","doi":"https://doi.org/10.1007/s40261-014-0237-7","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s40261-014-0237-7","pdf_url":null,"source":{"id":"https://openalex.org/S138241747","display_name":"Clinical Drug Investigation","issn_l":"0114-2402","issn":["0114-2402","1173-2563","1179-1918","2196-4920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Drug Investigation","raw_type":"journal-article"},{"id":"pmid:25312351","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25312351","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical drug investigation","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320324670","display_name":"Kitasato University","ror":"https://ror.org/00f2txz25"},{"id":"https://openalex.org/F4320337376","display_name":"NIH Clinical Center","ror":"https://ror.org/04vfsmv21"},{"id":"https://openalex.org/F4320337846","display_name":"UCB Pharma","ror":"https://ror.org/01n029866"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W105915516","https://openalex.org/W1028729263","https://openalex.org/W1550111394","https://openalex.org/W1970477044","https://openalex.org/W1970873847","https://openalex.org/W1972696118","https://openalex.org/W1976010985","https://openalex.org/W1996896888","https://openalex.org/W1997476734","https://openalex.org/W2005815716","https://openalex.org/W2047355574","https://openalex.org/W2062932814","https://openalex.org/W2075286165","https://openalex.org/W2082009141","https://openalex.org/W2090179946","https://openalex.org/W2114705698","https://openalex.org/W2133948398","https://openalex.org/W2146750707","https://openalex.org/W2165073784","https://openalex.org/W2246750959","https://openalex.org/W4241007920","https://openalex.org/W4248943794"],"related_works":["https://openalex.org/W4414370462","https://openalex.org/W4407758778","https://openalex.org/W4407898515","https://openalex.org/W3206934677","https://openalex.org/W4210387984","https://openalex.org/W3121047679","https://openalex.org/W4414004686","https://openalex.org/W4407338742","https://openalex.org/W2332493613","https://openalex.org/W4309119263"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2014164137","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
